Published on in Vol 10 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/60961, first published .
Preparing for the Implementation of Long-Acting Injectable Cabotegravir for HIV Pre-Exposure Prophylaxis Within the Brazilian Public Health System (ImPrEP CAB Brasil): Qualitative Study

Preparing for the Implementation of Long-Acting Injectable Cabotegravir for HIV Pre-Exposure Prophylaxis Within the Brazilian Public Health System (ImPrEP CAB Brasil): Qualitative Study

Preparing for the Implementation of Long-Acting Injectable Cabotegravir for HIV Pre-Exposure Prophylaxis Within the Brazilian Public Health System (ImPrEP CAB Brasil): Qualitative Study

Journals

  1. Barnett A, Unternaher J, Dimenstein N, Rakhmanina N. PrEP Implementation with Sexual and Gender Minority Youth: a Review on Barriers and Facilitators. Current Pediatrics Reports 2025;13(1) View
  2. Pimenta C, Mann C, Hoagland B, Carvalheira E, Jalil C, Benedetti M, Fernandes N, Coutinho C, Jalil E, Secco Torres Silva M, Trefiglio R, Farias A, Mourão M, Madruga J, de Lima J, Zonta R, O'Malley G, Veloso V, Grinsztejn B, Torres T. Exploring perceptions and preferences for PrEP choice and of an mHealth intervention: insights from the ImPrEP CAB‐Brasil study. Journal of the International AIDS Society 2025;28(S2) View
  3. Zamantakis A, Gomez W, Lukose L, Pachicano A, Kassanits J, Katomski A, Rosenberg-Carlson E, Willging C, Nelson L, Valeriano T, Karris M, Blumenthal J, Rana A, Brewer R, Hamilton A, Kemp C, Humphries D, Benbow N, Kao U, Lee S, Jones J, Schwartz S, Beres L, Rosen J. Barriers to Same-Day Pre-exposure Prophylaxis (PrEP) Implementation in Federally Funded HIV Clinics Within High-Burden Areas of the U.S.: A Coincidence Analysis. AIDS and Behavior 2025 View
  4. Barreto K, Torres T, Freitas L, Hoagland B, Jalil E, Veloso V, Grinsztejn B, Luz P. Pre-exposure prophylaxis use and discontinuation among Brazilian gay, bisexual, and other men who have sex with men: examining the role of internalized homonegativity and discrimination. BMC Infectious Diseases 2025;25(1) View